Edwards Lifesciences posts Q4, 2012 gains, confirms guidance

February 4, 2013 by MassDevice staff

Profits for Edwards Lifesciences grew at strong double-digit clips during the 4th quarter and 2012 as the medical device company confirms its outlook for 2013.

Edwards Lifesciences

Edwards Lifesciences (NYSE:EW) handily beat Wall Street's expectations for its 4th-quarter and 2012 profits and confirmed its outlook for 2013 today after the market's close.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.